Search

everythinglearnresearchcommunity

for

Search:↓

Latanoprost, a glaucoma treatment, was found ineffective in treating hair loss in eyebrows and eyelashes.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

DPCP is effective for treating severe alopecia areata, but relapse is common.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Candida antigen is an effective and promising treatment for alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Low-dose intermittent corticosteroid therapy can effectively treat alopecia areata.

308 nm excimer phototherapy can help some people with alopecia areata regrow hair, especially if their condition is less severe.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

PRP is an effective and safe treatment for alopecia areata.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.